Neither tumor stage, disease activity, nor provision of active-anticancer therapy at COVID-19 diagnosis were enriched in non-survivors, whereas a striking and highly significant rise in mortality was seen for patients aged ≥65 and those with multiple co-morbidities.
← all excerpts
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
1
—
—